{"id":"tachosil-patches","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"TachoSil patches contain a combination of human fibrinogen and human thrombin that are released when the patch comes into contact with blood. This release of fibrinogen and thrombin triggers the coagulation cascade, leading to the formation of a fibrin clot that seals the wound and promotes hemostasis.","oneSentence":"TachoSil patches work by promoting hemostasis and tissue sealing through the release of fibrinogen and thrombin.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:37:21.247Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hemostasis and tissue sealing in surgical procedures"}]},"trialDetails":[{"nctId":"NCT04660721","phase":"PHASE1, PHASE2","title":"A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery","status":"COMPLETED","sponsor":"Sealantium Medical Ltd.","startDate":"2021-05-12","conditions":"Hemostasis, General Surgery","enrollment":33},{"nctId":"NCT06124209","phase":"PHASE4","title":"Use of Fibrin Sealant Patch for Vein Anastomosis During Deceased Donor Liver Transplantation- Randomized Clinical Trial","status":"UNKNOWN","sponsor":"Medical University of Warsaw","startDate":"2023-11-04","conditions":"Liver Transplant; Complications","enrollment":170},{"nctId":"NCT04065880","phase":"NA","title":"Neoveil® Versus TachoSil® for the Treatment of Pulmonary Air Leaks Following Lung Operation","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-04-01","conditions":"Prolonged Air Leak, Postoperative Air Leak","enrollment":46},{"nctId":"NCT01470677","phase":"PHASE3","title":"Tachosil for the Prevention of Symptomatic Lymph Cysts","status":"COMPLETED","sponsor":"Ruhr University of Bochum","startDate":"2011-11","conditions":"Endometrial Cancer, Cervical Cancer","enrollment":220},{"nctId":"NCT02311543","phase":"PHASE3","title":"Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer","status":"COMPLETED","sponsor":"Swiss Cancer Institute","startDate":"2015-03-18","conditions":"Breast Cancer","enrollment":142},{"nctId":"NCT03752606","phase":"PHASE4","title":"Application of Tachosil During Lymphadenectomy","status":"COMPLETED","sponsor":"Medical University of Lublin","startDate":"2013-11-29","conditions":"Lymphocele, Endometrial Cancer, Cervical Cancer","enrollment":50},{"nctId":"NCT03269955","phase":"PHASE4","title":"The Effect of Application of TachoSil® in Pancreatoduodenectomy","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2017-02-27","conditions":"Pancreatic Neoplasm, Pancreatic Periampullary Cancer, Pancreatic Bordeline Tumor","enrollment":126},{"nctId":"NCT01500135","phase":"PHASE3","title":"Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-03","conditions":"Bleeding","enrollment":150},{"nctId":"NCT01920958","phase":"","title":"Use of Tachosil® for Lymph Sealing During Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2012-09","conditions":"Lymph Node Resection","enrollment":233},{"nctId":"NCT01192022","phase":"PHASE3","title":"TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery","status":"COMPLETED","sponsor":"Takeda","startDate":"2010-08","conditions":"Hemorrhage","enrollment":253},{"nctId":"NCT02105506","phase":"NA","title":"Safety and Feasibility of TachoSil®: Application on Esophageal Anastomoses","status":"COMPLETED","sponsor":"R. van Hillegersberg","startDate":"2012-09","conditions":"Esophageal Disease, Gastric Disease","enrollment":15},{"nctId":"NCT01639833","phase":"NA","title":"A Premarket, Prospective, Randomized, Single-Blind Study to Compare the Veriset™ Hemostatic Patch to TachoSil® as an Adjunct to Hemostasis in Subjects Undergoing Cardiovascular Surgery","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2012-08","conditions":"Cardiac Surgical Procedures, Hemorrhage","enrollment":90},{"nctId":"NCT01324349","phase":"NA","title":"Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2011-02","conditions":"Liver Disease","enrollment":50},{"nctId":"NCT00852826","phase":"PHASE4","title":"Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy","status":"COMPLETED","sponsor":"Hospital Universitario Virgen de la Arrixaca","startDate":"2008-01","conditions":"Seroma","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"TachoSil® patches","genericName":"TachoSil® patches","companyName":"Swiss Cancer Institute","companyId":"swiss-cancer-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TachoSil patches work by promoting hemostasis and tissue sealing through the release of fibrinogen and thrombin. Used for Hemostasis and tissue sealing in surgical procedures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}